The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.00
Bid: 232.00
Ask: 240.00
Change: 0.00 (0.00%)
Spread: 8.00 (3.448%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 236.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

18 Nov 2020 07:00

RNS Number : 6501F
Animalcare Group PLC
18 November 2020
 

ANIMALCARE GROUP PLC

 (the "Company")

Grant of options

 

18 November 2020. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 17 November 2020, nil-cost options over a total of 377,120 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to the Executive Directors and PDMRs of the Company and to members of the Leadership Team pursuant to the Company's Long Term Incentive Plan.

 

The awards will normally vest on 31 December 2023 subject to the following performance criteria being met over the three-year financial period ending 31 December 2023. The performance criteria which are based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) are as follows:

 

Earnings Per Share growth per annum

Extent to which EPS tranche will vest

Less than 3%

0%

3%

25%

8%

100%

Between 3% and 8%

Between 25% and 100% on a straight line basis

 

Rank of the Company's TSR compared to the Comparator Group

Extent to which the TSR tranche will vest

Upper quartile or above

100%

Between median and upper quartile

Pro rata between 25% and 100% on a ranking basis

Median

25%

Below median

0%

 

50% of the option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will only vest in part. 

 

After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:

 

PDMR

Options Awarded

Total Options

Ordinary Shares

Jennifer Winter

165,761

 

343,331

 

0

Chris Brewster

66,848

 

143,484

280,513

 

Options over a further 144,511 ordinary shares were granted to other members of the Leadership Team.

 

The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:

 

ANNEX

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Jennifer Winter, Chief Executive Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Ms Winter is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 165,761 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

17 November 2020

g)

 

Place of the transaction

Outside a trading venue

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Chris Brewster, Chief Financial Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Mr Brewster is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 66,848 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

17 November 2020

g)

 

Place of the transaction

Outside a trading venue

 

 

Animalcare Group plc

Tel: +44 (0)1904 487 687

Chris Brewster, Chief Financial Officer

 

Media relations

communications@animalcaregroup.com

 

Panmure Gordon - Nominated Adviser and Broker

Tel: +44 (0)20 7886 2500

Corporate Finance

 

Freddy Crossley / Emma Earl

 

Corporate Broking

Rupert Dearden

 

 

 

About Animalcare www.animalcaregroup.com

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 32 countries in Europe and a further 16 worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDBBDBCXBDGGR
Date   Source Headline
12th Jul 202111:04 amRNSNotification of Major Holding
12th Jul 20217:00 amRNSExercise of options
9th Jul 20214:59 pmRNSNotification of Major Holding
9th Jul 20213:20 pmRNSNotification of Major Holding
8th Jul 20215:45 pmRNSResult of Secondary Placing
8th Jul 20214:41 pmRNSSecond Price Monitoring Extn
8th Jul 20214:35 pmRNSPrice Monitoring Extension
8th Jul 20212:06 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
8th Jul 20211:00 pmRNSProposed Secondary Placing
1st Jul 20217:00 amRNSTotal Voting Rights
21st Jun 20217:00 amRNSExercise of options
17th Jun 202110:17 amRNSDirector/PDMR Notification
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20215:03 pmRNSResult of 2021 AGM
17th May 20217:00 amRNSAnnual Report 2020 and Notice of AGM
22nd Apr 20217:00 amRNSDaxocox approved by EU and UK authorities
30th Mar 20217:00 amRNSFull Year Results 2020
23rd Mar 20217:00 amRNSNotification of major holding
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20213:43 pmRNSDaxocox receives positive opinion from CVMP in EU
8th Feb 20212:46 pmRNSNotification of major holding
1st Feb 20217:00 amRNSAppointment of Nominated Advisor and Joint Broker
21st Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
18th Nov 20207:00 amRNSGrant of options
29th Sep 20207:00 amRNSInterim Results H1 2020
28th Sep 20207:00 amRNSAnimalcare and Kane Biotech to target biofilms
23rd Jul 20207:00 amRNSTrading Update and Notice of Results
30th Jun 20204:00 pmRNSResult of AGM 2020
9th Jun 20203:55 pmRNS2019 Annual Report and Notice of 2020 AGM
28th May 20207:00 amRNSFull year results 2019
18th May 202011:20 amRNSNotice of Full Year 2019 Results
25th Mar 20207:00 amRNSTrading update, revised date for full year results
23rd Jan 20207:00 amRNSTrading Update & Notice of Results
17th Jan 20208:55 amRNSHoldings in Company
24th Sep 20197:00 amRNSHalf Year Results
25th Jul 20197:00 amRNSDirectorate Change
23rd Jul 20197:00 amRNSTrading Update & Notice of Results
16th Jul 201911:37 amRNSNotification of major holdings
25th Jun 20191:40 pmRNSResult of AGM
19th Jun 20193:52 pmRNSBoard change
10th Jun 20192:55 pmRNSDirector/PDMR Shareholding
22nd May 20197:00 amRNSAnnual Report and Notice of Annual General Meeting
8th May 201910:35 amRNSDividend Declaration
30th Apr 20197:00 amRNS2018 Full Year Results
21st Jan 20197:00 amRNSTrading Update and Notice of Results
30th Oct 20187:50 amRNSAdditional Listing
1st Oct 201812:45 pmRNSAdditional Listing
25th Sep 20185:36 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.